FROM SINGLE USE TO CIRCULAR USE Increased attention from Governments, health services and industry evolving policy and regulatory frameworks
With
Jane Crowe, Vice President Asia Pacific
Cardinal Health
Neroli Manning
Managing Director, ANZ at Cardinal Health
Dan Vukelich, CEO and President,
Association of Medical Device Reprocessors (AMDR)
SEGMENT
Filmed in Sydney | September 2026
Healthcare sustainability is increasingly becoming a strategic priority, extending beyond environmental goals to influence procurement, regulation, costs and supply-chain resilience. Against this backdrop, medical device reprocessing is emerging as a potential pathway towards a more circular healthcare system.
In September 2026 at the RegConnect26 Summit, hosted by the Medical Technology Association of Australia, Dan Vukelich, President and CEO of the Association of Medical Device Reprocessors, outlined the international evolution of reprocessing, remanufacturing and refurbishment of single-use medical devices (SUDs).
Drawing on more than two decades of experience across the United States, Europe and other major healthcare markets, Vukelich explored how these models are increasingly influencing sustainability strategies, procurement policies and regulatory frameworks. Reprocessing can help reduce medical waste and emissions while improving resource efficiency and strengthening supply-chain resilience.
In an interview with Australian Health Journal, Vukelich was joined by Jane Crowe and Neroli Manning from Cardinal Health, a global medical device and healthcare company. The discussion examined the company’s experience in the United States and its plans to establish a remanufacturing facility in Newcastle.
Expected to open in 2027, the facility will be among the few in Australia capable of remanufacturing single-use medical devices, with products returned to circulation following quality testing and high-level disinfection processes.
Vukelich highlighted the need for greater regulatory clarity around cleaning validation, cycle limits and demonstrating that reprocessed devices meet medical device manufacturing standards. “These devices are as safe and as effective as original equipment,” he said.
The speakers also identified opportunities for Australia to develop green MedTech manufacturing capabilities and potentially expand sustainable healthcare solutions across the Asia-Pacific region.
– Media access credit: RegConnect 2026 Summit | Medical Technology Association of Australia (MTAA)
– PowerPoint slides supplied by Association of Medical Device Reprocessors (AMDR)
Source: Written by Australian Health Journal using AI
-
Mission to raise awareness of sarcoma and need for clinical trial funding
Sarcoma, a rare and aggressive cancer, remains the deadliest cancer for children and young adults, accounting for nearly one third (30%) of cancer-related deaths among those aged 15–24 and one tenth (10%) of those aged 0–14. Further, still severely under-diagnosed, sarcoma only accounts for one sixth (15%) of all cancer diagnoses in the 15 – 24 age group, and less than a tenth (8%) among children under 10.
-
Allied Health Leader shares career insights
Mirella Vagnarelli is a distinguished healthcare leader with proven expertise across South Australia and the United Kingdom, where she has successfully led large, multidisciplinary teams. Holding a Master of Business Administration (Health) from Flinders University, she earned Fellowship status with the Australasian College of Health Service Management in 2022. In 2023, Mirella was honoured as a scholarship recipient for the prestigious ‘Women in Leadership’ Program at the Monash Centre for Health Research and Implementation.
-
Reporting on Australian childhood visual impairment: the first 10 years
The Australian Childhood Vision Impairment Register (ACVIR), the first of its kind in Australia, captures uniquely Australian data which is used to improve services for children with vision impairment. The data is also available to researchers who work in the area of eye disease and disorders of vision.
